Novavax NVAX EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from Novavax’s reported figures.
The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Novavax's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Novavax's EBIT?
- Novavax (NVAX) reported EBIT of -$15.43M in Q1 2026.
- How has Novavax's EBIT changed year-over-year?
- Novavax's EBIT decreased by 103.0% year-over-year, from $515.51M to -$15.43M.
- What is the long-term trend for Novavax's EBIT?
- Over 4 years (2021 to 2025), Novavax's EBIT has grown at a -28.0% compound annual growth rate (CAGR), from -$1.69B to $452.8M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.